SuperworthDelcath Systems profit margin DCTH
Gross, operating and net profit as a share of revenue over the last twelve months, from 2024.
- Net margin, 12 months
- 0.6%
- Operating margin, 12 months
- −1.9%
- Net margin on a year earlier
- −2.6 pts
- Peer median
- 7.8%
Over the twelve months to Jun 30, 2026, Delcath Systems kept 0.6% of its revenue as net profit, with an operating margin of −1.9% and a gross margin of 87.1%.
The median for 10 medical instruments and supplies stocks of a similar size is 7.8%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 3.2% | 0.8% | 86.2% |
| FY2024 | −70.9% | −33.4% | 83.4% |
| FY2023 | n/a | n/a | 69.2% |
| FY2022 | n/a | n/a | 74.8% |
| FY2021 | n/a | n/a | 81.1% |
| FY2020 | n/a | n/a | 61.1% |
| FY2019 | n/a | n/a | 54.5% |
| FY2018 | n/a | n/a | 70.4% |
| FY2017 | n/a | n/a | 74.2% |
| FY2016 | n/a | n/a | 72.4% |
| FY2015 | n/a | n/a | 73.6% |
| FY2014 | n/a | n/a | 72.8% |
| FY2013 | n/a | n/a | 41.3% |
| FY2012 | n/a | n/a | 88.7% |
| FY2011 | n/a | n/a | n/a |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 0.6% | −2.6 pts | −1.9% | |
| Q1 FY26 | 0.6% | +27.0 pts | −1.8% | |
| Q4 FY25 | 3.2% | +74.1 pts | 0.8% | |
| Q3 FY25 | 1.5% | n/a | 7.4% | |
| Q2 FY25 | 3.2% | n/a | 7.1% | |
| Q1 FY25 | −26.4% | n/a | −2.8% | |
| Q4 FY24 | −70.9% | n/a | −33.4% | |
| Q3 FY24 | n/a | n/a | n/a | |
| Q2 FY24 | n/a | n/a | n/a | |
| Q1 FY24 | n/a | n/a | n/a | |
| Q4 FY23 | n/a | n/a | n/a | |
| Q3 FY23 | n/a | n/a | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Delcath Systems' size, closest first, today.
| Company | Profit margin |
|---|---|
| DCTHDelcath Systems | 0.6% |
| TCMDTactile Systems Technology | 7.1% |
| MDXGMimedx | 1.8% |
| EMBCEmbecta | 8.6% |
| MOVMovado | 6.0% |
| INFUInfuSystem | 6.0% |
| UTMDUtah Medical Products | 29.0% |
| IRMDIradimed | 26.7% |
| STAAStaar Surgical | 1.1% |
| PDEXPro DEX | 17.6% |
| BVSBioventus | 9.4% |
| Peer median | 7.8% |
Where Delcath Systems ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Delcath Systems
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.